---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-21-001433"
form_type: "8-K"
ticker: "FUST"
cik: "0001636051"
company_name: "FUSE GROUP HOLDING INC."
filed_at: "2021-10-01T23:59:59+00:00"
generated_at: "2026-06-28T23:58:57.654333+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Fuse Group terminates E-Mo Biotech acquisition; restates Q1, Q2 2021 financials

## Summary
- Terminated Share Exchange Agreement to acquire E-Mo Biotech; no shares issued or exchanged.
- Will restate financials for quarters ended March 31 and June 30, 2021 due to reclassification error.
- 14,285,715 shares issued as prepayment for mining rights reclassified to equity deduction per SAB Topic 4:E.
- Non-reliance on previously issued Q1 and Q2 2021 financial statements; amendment to 10-Qs planned.

## SEC filing metadata
- accession: 0001185185-21-001433
- form_type: 8-K
- ticker: FUST
- cik: 0001636051
- company_name: FUSE GROUP HOLDING INC.
- filed_at: 2021-10-01T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 1.02, 4.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636051/000118518521001433/0001185185-21-001433-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636051/000118518521001433/fuseent20211001_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-21-001433
- JSON: https://secwatch.observer/filing/0001185185-21-001433.json
- Plain text: https://secwatch.observer/filing/0001185185-21-001433.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.